Gene vaccination with naked plasmid DNA: Mechanism of CTL priming

被引:396
|
作者
Corr, M
Lee, DJ
Carson, DA
Tighe, H
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
[2] UNIV CALIF SAN DIEGO,SAM & ROSE STEIN INST RES AGING,LA JOLLA,CA 92093
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1996年 / 184卷 / 04期
关键词
D O I
10.1084/jem.184.4.1555
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The injection of naked plasmid DNA directly into the muscle cells of mice has been shown to induce potent humoral and cellular immune responses. The generation of a cytotoxic T lymphocyte (CTL) response after plasmid DNA injection may involve the presentation of the expressed antigen in the context of the injected myocytes' endogenous major histocompatibility (MHC)-encoded class I molecules or may use the MHC molecules of bone marrow-derived antigen presenting cells (APC) which are capable of providing co-stimulation as well. To resolve which cell type provides the specific restricting element for this method of vaccination we generated parent-->F1 bone marrow chimeras in which H-2(oxd) recipient mice received bone marrow that expressed only H-2(b) or H-2(d) MHC molecules. These mice were injected intramuscularly with naked plasmid DNA that encoded the nucleoprotein from the A/PR/8/34 influenza strain, which as a single antigen has epitopes for both H-2D(b) and H-2K(d). The resulting CTL responses were restricted to the MHC haplotype of the bone marrow alone and not to the second haplotype expressed by the recipient's myocytes. The role of somatic tissues that express protein from injected plasmids may be to serve as a reservoir for that antigen which is then transferred to the APC. Consequently, our data show that the mechanism of priming in this novel method for vaccination uses the MHC from bone marrow-derived APC, which are efficient at providing all of the necessary signals for priming the T cell.
引用
收藏
页码:1555 / 1560
页数:6
相关论文
共 50 条
  • [21] Uptake and trafficking of naked plasmid DNA in human keratinocytes
    Basner-Tschakarjan, E
    Mirmohammadsadegh, A
    Maschke, J
    Hengge, UR
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 249 - 249
  • [22] Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models
    Kobayashi, N
    Kuramoto, T
    Chen, S
    Watanabe, Y
    Takakura, Y
    MOLECULAR THERAPY, 2002, 6 (06) : 737 - 744
  • [23] Gene therapy in cardiac surgery: intramyocardial injection of naked plasmid DNA for chronic myocardial ischemia
    Heilmann, CAU
    Attmann, T
    Thiem, A
    Haffner, E
    Beyersdorf, F
    Lutter, G
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 24 (05) : 785 - 793
  • [24] Treatment of hyperbilirubinemia in the Gunn rat by intravascular gene transfer into muscle with naked plasmid DNA (pDNA)
    Danko, I
    Jia, Z
    MOLECULAR THERAPY, 2004, 9 : S399 - S399
  • [25] Process development for production of pharmaceutical grade plasmid DNA to be used in gene therapy and DNA vaccination
    Lueer, C.
    Bohle, K.
    Ross, A.
    Ziehr, H.
    HUMAN GENE THERAPY, 2011, 22 (10) : A74 - A74
  • [26] Optimization and delivery of plasmid DNA for vaccination
    Jechlinger, Wolfgang
    EXPERT REVIEW OF VACCINES, 2006, 5 (06) : 803 - 825
  • [27] DNA plasmid vaccination for multiple sclerosis
    Stueve, Olaf
    Eagar, Todd N.
    Frohman, Elliot M.
    Cravens, Petra D.
    ARCHIVES OF NEUROLOGY, 2007, 64 (10) : 1385 - 1386
  • [28] Ultrasound-mediated gene delivery of naked plasmid DNA in skeletal muscles: A case for bolus injections
    Pedro, Gomes Sanches
    Muehlmeister, Mareike
    Seip, Ralf
    Kaijzel, Eric
    Loewik, Clemens
    Boehmer, Marcel
    Tiemann, Klaus
    Gruell, Holger
    JOURNAL OF CONTROLLED RELEASE, 2014, 195 : 130 - 137
  • [29] The Mechanism of Naked DNA Uptake and Expression
    Wolff, Jon A.
    Budker, Vladimir
    NON-VIRAL VECTORS FOR GENE THERAPY, SECOND EDITION: PART 2, 2005, 54 : 3 - 20
  • [30] M cell DNA vaccination for CTL immunity to HIV
    Wang, XH
    Hone, DM
    Haddad, A
    Shata, MT
    Pascual, DW
    JOURNAL OF IMMUNOLOGY, 2003, 171 (09): : 4717 - 4725